NCT01177319View on ClinicalTrials.gov

Glutathione (GSH) In The Treatment of Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

Glutathione

Trial Locations (1)

33606

USF Parkinson's Disease and Movement Disorders Center, Tampa

All Listed Sponsors
collaborator

Wellness Health & Pharmaceuticals, Inc.

INDUSTRY

lead

University of South Florida

OTHER

NCT01177319 - Glutathione (GSH) In The Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter